The National Academies
What You Need To Know About Infectious Disease
Prevention & Treatment
International Cooperation
National borders are trivial impediments to infectious disease threats. In the highly interconnected and readily traversed global village of our time, one nation’s problem soon becomes every nation’s problem. Therefore, strategies must be implemented worldwide, not just nationally, in order to have a true impact.
Explore Other Topics
Disease Watchlist
What do you know about infectious disease?
“Antibiotic resistance” refers to:
- The reluctance of physicians to prescribe antibiotics
- An underground movement against pharmaceutical companies
- The ability of bacteria to resist the effects of an antibiotic
-
Sorry, that’s incorrect.
“Antibiotic resistance” refers to the ability of bacteria to resist the effects of an antibiotic. Antibiotic resistance occurs when bacteria undergo a genetic change that reduces or eliminates the effectiveness of drugs or other agents designed to cure or prevent infection.
-
Sorry, that’s incorrect.
“Antibiotic resistance” refers to the ability of bacteria to resist the effects of an antibiotic. Antibiotic resistance occurs when bacteria undergo a genetic change that reduces or eliminates the effectiveness of drugs or other agents designed to cure or prevent infection.
-
Correct!
“Antibiotic resistance” refers to the ability of bacteria to resist the effects of an antibiotic. Antibiotic resistance occurs when bacteria undergo a genetic change that reduces or eliminates the effectiveness of drugs or other agents designed to cure or prevent infection.
Infectious Disease Defined
- Egg Cell
The female gamete, or sex cell, which carries the hereditary material of the female parent and unites with the male sperm cell during sexual reproduction.
National Academies Press
Search the National Academies Press website by selecting one of these related terms.
Source Material
- Infectious Disease Movement in a Borderless World—Workshop Summary (2010)
- Global Issues in Water, Sanitation, and Health—Workshop Summary (2009)
- Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases (2009)
- The U.S. Commitment to Global Health: Recommendations for the Public and Private Sectors (2009)
- Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin—Workshop Summary (2008)
- Global Infectious Disease Surveillance and Detection: Assessing the Challenges, Finding Solutions—Workshop Summary (2007)
- Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance (2004)
